Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
507.2 SEK | -2.64% | -0.97% | -5.58% |
Mar. 05 | Camurus' New Drug Application for Acromegaly Treatment Accepted by US FDA | MT |
Mar. 05 | Camurus AB Announces FDA Acceptance of NDA Submission for Oclaiz? for Treatment of Acromegaly | CI |
- Stock
- Equities
- Stock Camurus AB - Nasdaq Stockholm
- News Camurus AB